Close

Apricus Biosciences (APRI) Reports Vitaros Approval in Argentina to Treat ED

Go back to Apricus Biosciences (APRI) Reports Vitaros Approval in Argentina to Treat ED
APRICUS BIOSCIENCES (NASDAQ: APRI) Delayed: 0.22 --0 (-0%)
Previous Close $0.22    52 Week High $2.98 
Open $9.22    52 Week Low $0.26 
Day High $0.22    P/E N/A 
Day Low $0.22    EPS $-0.92 
Volume 17,798